Rani Therapeutics Holdings (RANI) Long-Term Deferred Tax (2021 - 2024)
Rani Therapeutics Holdings' (RANI) quarterly Long-Term Deferred Tax came in at $18.9 million in Q3 2024, up 0.53% year-on-year from $18.8 million in Q4 2023, and little changed quarter-over-quarter from $18.9 million in Q2 2024.
Rani Therapeutics Holdings (RANI) Long-Term Deferred Tax (2021 - 2024) Analysis & Trends
Rani Therapeutics Holdings' Long-Term Deferred Tax history runs 4 years deep, the most recent figure standing at $18.9 million for Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rani Therapeutics Holdings | 160.20 Mn | 167.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 18.90 Mn |
| Jun 30, 2024 | 18.90 Mn |
| Mar 31, 2024 | 18.90 Mn |
| Sep 30, 2023 | 18.80 Mn |
| Jun 30, 2023 | 18.70 Mn |
| Mar 31, 2023 | 18.70 Mn |
| Sep 30, 2022 | 18.00 Mn |
| Jun 30, 2022 | 18.30 Mn |
| Mar 31, 2022 | 17.40 Mn |
| Jun 30, 2021 | 3.41 Mn |